Antibodies binding to vista at acidic ph

MYPI2025003891A0Undetermined Publication Date: 2018-09-14FIVE PRIME THERAPEUTICS INC +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MYPI2025003891
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Priority Date
2018-02-28
Filing Date
2018-03-13
Publication Date
2018-09-14
Patent Text Reader

Abstract

The present application relates to antibodies specifically binding to the V-domain immunoglobulin-containing suppressor of T-cell activation (VISTA) at acidic pH and their use in cancer treatment. In some embodiments, the antibodies bind specifically to human VISTA at acidic pH, but do not significantly bind to human VISTA at neutral or physiological pH [Fig 1A.]
Need to check novelty before this filing date? Find Prior Art